Xtant Medical Holdings, Inc.
XTNT
$0.36
-$0.02-6.26%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.28% | -35.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.28% | -35.46% | |||
| Cost of Revenue | 8.84% | -38.96% | |||
| Gross Profit | 11.35% | -32.57% | |||
| SG&A Expenses | 16.22% | -20.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.25% | -28.51% | |||
| Operating Income | -42.63% | -209.64% | |||
| Income Before Tax | -205.03% | -291.61% | |||
| Income Tax Expenses | 170.37% | -98.25% | |||
| Earnings from Continuing Operations | -204.73% | -5,519.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -204.73% | -5,519.30% | |||
| EBIT | -42.63% | -209.64% | |||
| EBITDA | -53.24% | -373.03% | |||
| EPS Basic | -203.62% | -5,625.00% | |||
| Normalized Basic EPS | -203.65% | -82.67% | |||
| EPS Diluted | -216.74% | -- | |||
| Normalized Diluted EPS | -203.65% | -95.71% | |||
| Average Basic Shares Outstanding | 0.14% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.14% | -6.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||